COVID-19或冠状病毒感染，是一种由冠状病毒引起的急性呼吸道疾病，可以发展成危及生命的ARDS形式。体外膜氧合（ECMO）是一种非常有效的治疗危及生命的情况。与ECMO相关的许多并发症之一是出血。由于多种因素，COVID患者存在脑出血的风险，包括药物对ACE2受体的作用，导致高血压，以及高凝状态，失调的免疫反应，DIC,以及抗凝剂的使用。
COVID-19, or coronavirus infection, is an acute respiratory illness caused by the corona virus that can develop into a life-threatening form of ARDS. Extracorporeal membrane oxygenation (ECMO) is a highly effective treatment for life-threatening instances. One of the many complications associated with ECMO was bleeding. COVID patients are at risk for intracerebral bleeding due to several factors, including the drug\'s action on ACE2 receptors, leading to hypertension, as well as hypercoagulability, dysregulated immune response, DIC, and the use of anticoagulants.
PDF(Pubmed)